Nanoparticle-delivered RNA reduces neuroinflammation in lab tests
MIT researchers find that in mice and human cell cultures, lipid nanoparticles can deliver a potential therapy for inflammation in the brain, a prominent symptom in Alzheimer’s.
MIT researchers find that in mice and human cell cultures, lipid nanoparticles can deliver a potential therapy for inflammation in the brain, a prominent symptom in Alzheimer’s.
MIT professor combines nanoscience and viruses to develop solutions in energy, environment, and medicine.
A new method enables optical devices that more closely match their design specifications, boosting accuracy and efficiency.
Human volunteers will soon begin receiving an HIV vaccine that contains an adjuvant developed in Irvine’s lab, which helps to boost B cell responses to the vaccine.
Researchers are working to advance the field of glycoscience, illuminating the essential role of carbohydrates for human health and disease.
Using fluorescent labels that switch on and off, MIT engineers can study how molecules in a cell interact to control the cell’s behavior.
By analyzing bacterial data, researchers have discovered thousands of rare new CRISPR systems that have a range of functions and could enable gene editing, diagnostics, and more.
Seed projects, posters represent a wide range of labs working on technologies, therapeutic strategies, and fundamental research to advance understanding of age-related neurodegenerative disease.
MIT researchers will partner on interdisciplinary research in human biology and disease.
Glyco enthusiasts from MIT and beyond recently gathered in Bartos Theatre to enjoy presentations of the latest advancements in glycobiology research.
Thirteen new graduate student fellows will pursue exciting new paths of knowledge and discovery.
The vibrating platform could be useful for growing artificial muscles to power soft robots and testing therapies for neuromuscular diseases.
New research finds RNA-guided enzymes called Fanzors are widespread among eukaryotic organisms.
Five MIT faculty, along with seven additional affiliates, are honored for outstanding contributions to medical research.
By focusing on causal relationships in genome regulation, a new AI method could help scientists identify new immunotherapy techniques or regenerative therapies.